Literature DB >> 22669104

In regard to Lassman et al.

Eduardo Weltman, Suzana Maria Fleury Malheiros.   

Abstract

Mesh：

Year:  2012        PMID： 22669104      PMCID： PMC3367856          DOI： 10.1093/neuonc/nos127

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN： 1522-8517            Impact factor:   12.300


× No keyword cloud information.
  5 in total

1.  THERAPEUTIC CONSIDERATIONS IN TUMORS AFFECTING THE CENTRAL NERVOUS SYSTEM: OLIGODENDROGLIOMAS.

Authors:  G E SHELINE; E BOLDREY; P KARLSBERG; T L PHILLIPS
Journal:  Radiology       Date:  1964-01       Impact factor: 11.105

2.  Anaplastic oligodendroglial tumors: a tale of two trials.

Authors:  Mark R Gilbert; Frederick F Lang
Journal:  J Clin Oncol       Date:  2006-06-20       Impact factor: 44.544

3.  Phase III trial of chemotherapy plus radiotherapy compared with radiotherapy alone for pure and mixed anaplastic oligodendroglioma: Intergroup Radiation Therapy Oncology Group Trial 9402.

Authors:  Gregory Cairncross; Brian Berkey; Edward Shaw; Robert Jenkins; Bernd Scheithauer; David Brachman; Jan Buckner; Karen Fink; Luis Souhami; Normand Laperierre; Minesh Mehta; Walter Curran
Journal:  J Clin Oncol       Date:  2006-06-20       Impact factor: 44.544

4.  Adjuvant procarbazine, lomustine, and vincristine improves progression-free survival but not overall survival in newly diagnosed anaplastic oligodendrogliomas and oligoastrocytomas: a randomized European Organisation for Research and Treatment of Cancer phase III trial.

Authors:  Martin J van den Bent; Antoine F Carpentier; Alba A Brandes; Marc Sanson; Martin J B Taphoorn; Hans J J A Bernsen; Marc Frenay; Cees C Tijssen; Wolfgang Grisold; Laslo Sipos; Hanny Haaxma-Reiche; Johannes M Kros; Mathilde C M van Kouwenhoven; Charles J Vecht; Anouk Allgeier; Denis Lacombe; Thierry Gorlia
Journal:  J Clin Oncol       Date:  2006-06-20       Impact factor: 44.544

5.  Statistical analysis of clinicopathological features, radiotherapy, and survival in 170 cases of oligodendroglioma.

Authors:  K F Lindegaard; S J Mørk; G E Eide; T B Halvorsen; R Hatlevoll; T Solgaard; O Dahl; J Ganz
Journal:  J Neurosurg       Date:  1987-08       Impact factor: 5.115
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.